Swiss National Bank Decreases Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Swiss National Bank trimmed its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 0.6% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 339,300 shares of the company’s stock after selling 2,000 shares during the quarter. Swiss National Bank owned 0.20% of Option Care Health worth $10,620,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also bought and sold shares of the company. Blue Trust Inc. grew its holdings in Option Care Health by 14.8% during the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock valued at $81,000 after purchasing an additional 377 shares during the last quarter. GAMMA Investing LLC grew its stake in shares of Option Care Health by 110.6% during the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after buying an additional 471 shares during the last quarter. Trust Point Inc. raised its holdings in shares of Option Care Health by 2.6% in the third quarter. Trust Point Inc. now owns 24,124 shares of the company’s stock worth $755,000 after buying an additional 622 shares during the period. Nisa Investment Advisors LLC lifted its stake in shares of Option Care Health by 5.4% during the 2nd quarter. Nisa Investment Advisors LLC now owns 13,581 shares of the company’s stock worth $376,000 after acquiring an additional 690 shares during the last quarter. Finally, KBC Group NV boosted its holdings in Option Care Health by 16.2% during the 3rd quarter. KBC Group NV now owns 5,013 shares of the company’s stock valued at $157,000 after acquiring an additional 700 shares during the period. Institutional investors own 98.05% of the company’s stock.

Analysts Set New Price Targets

OPCH has been the topic of several recent analyst reports. JMP Securities raised their price target on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research note on Monday, September 30th. Jefferies Financial Group lowered shares of Option Care Health from a “buy” rating to a “hold” rating and reduced their target price for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. Bank of America lowered Option Care Health from a “buy” rating to a “neutral” rating and lowered their price target for the company from $43.00 to $29.00 in a report on Wednesday, October 30th. Truist Financial decreased their target price on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Finally, The Goldman Sachs Group downgraded Option Care Health from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $30.83.

Option Care Health Stock Performance

Shares of NASDAQ:OPCH opened at $23.13 on Monday. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The company has a market capitalization of $3.94 billion, a price-to-earnings ratio of 19.44, a price-to-earnings-growth ratio of 2.33 and a beta of 1.32. The firm has a 50 day moving average of $27.62 and a 200 day moving average of $29.09. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $34.63.

Insider Transactions at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of Option Care Health stock in a transaction that occurred on Friday, November 8th. The stock was purchased at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the purchase, the director now directly owns 326,334 shares in the company, valued at $7,355,568.36. The trade was a 15.18 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Corporate insiders own 0.64% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.